Qualitative evidence of anti-Yo-specific intrathecal antibody synthesis in patients with paraneoplastic cerebellar degeneration (Q43826251)

27 November 2017

Qualitative evidence of anti-Yo-specific intrathecal antibody synthesis in patients with paraneoplastic cerebellar degeneration (English)

1 reference

27 November 2017

1 reference

Oliver Stich

1

1 reference

27 November 2017

Francesc Graus

series ordinal

2

1 reference

27 November 2017

Christiane Rasiah

series ordinal

3

1 reference

27 November 2017

Sebastian Rauer

series ordinal

4

1 reference

27 November 2017

language of work or name

1 reference

1 August 2003

1 reference

Journal of Neuroimmunology

27 November 2017

1 reference

27 November 2017

141

1 reference

27 November 2017

1-2

1 reference

27 November 2017

165-169

1 reference

Anti-HIV antibodies in the CSF of AIDS patients: a serological and immunoblotting study

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900257-1

7 January 2021

Biochemical findings in multiple sclerosis IV. Isoelectric focusing of the CSF gamma globulins in multiple sclerosis (262 cases) and other neurological diseases (272 cases).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900257-1

7 January 2021

Cloning of a leucine-zipper protein recognized by the sera of patients with antibody-associated paraneoplastic cerebellar degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900257-1

7 January 2021

Paraneoplastic cerebellar degeneration with anti-Yo antibody in a man

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900257-1

7 January 2021

Autoantibody synthesis in the central nervous system of patients with paraneoplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900257-1

7 January 2021

Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900257-1

7 January 2021

Selective concentration of anti-Purkinje cell antibody in the CSF of two patients with paraneoplastic cerebellar degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900257-1

7 January 2021

Association of anti-Yo (type I) antibody with paraneoplastic cerebellar degeneration in the setting of transitional cell carcinoma of the bladder: Detection of Yo antigen in tumor tissue and fall in antibody titers following tumor removal

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900257-1

7 January 2021

Affinity immunoblotting: rapid and sensitive detection of oligoclonal IgG, IgA and IgM in unconcentrated CSF by agarose isoelectric focusing

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900257-1

7 January 2021

Intrathecal immune response in neuroborreliosis: importance of cross-reactive antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900257-1

7 January 2021

Intrathecal synthesis of specific antibodies in neuroborreliosis. Comparison of different ELISA techniques and calculation methods

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900257-1

7 January 2021

Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with adenocarcinoma of unknown origin.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900257-1

7 January 2021

Multiple sclerosis: possible immunological mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900257-1

7 January 2021

Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900257-1

7 January 2021

Paraneoplastic cerebellar degeneration. I. A clinical analysis of 55 anti-Yo antibody-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900257-1

7 January 2021

Paraneoplastic temporal lobe epilepsy and anti-Yo autoantibody.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900257-1

7 January 2021

Paraneoplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900257-1

7 January 2021

Demonstration of anti-HuD specific oligoclonal bands in the cerebrospinal fluid from patients with paraneoplastic neurological syndromes. Qualitative evidence of anti-HuD specific IgG-synthesis in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900257-1

7 January 2021

Anti-Yo antibodies and cerebellar degeneration in a man with adenocarcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900257-1

7 January 2021

Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900257-1

7 January 2021

Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell loss

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900257-1

7 January 2021

Herpes simplex virus encephalitis: Intrathecal synthesis of oligoclonal virus-specific IgG, IgA and IgM antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900257-1

7 January 2021

Intrathecal synthesis of the anti-Hu antibody in patients with paraneoplastic encephalomyelitis or sensory neuronopathy: clinical-immunologic correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900257-1

7 January 2021

Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900257-1

7 January 2021

10.1016/S0165-5728(03)00257-1

Identifiers

DOI

1 reference

27 November 2017

1 reference